Item: Tata India Pharma & Healthcare Fund Direct Growth
Rating: Unrated
Author: Morningstar

Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth

12.053 (0.418%)

NAV on July 03, 2020

Category Equity:
Sector - Healthcare

Investment StyleBox

Large Growth

Total Assets 235 cr

Turnover Ratio 47.61%

Expense Ratio 1.20%

Exit Load 0.25%if redeemed within
3 Months0.00%if redeemed after 3 Months

Returns

1M: 0.21%
1Y: 30.09%
3M: 22.57%
3Y: 10.36%
6M: 21.00%
5Y: N/A

Min Investment 5,000

Buy Now Start SIP

ADDITIONAL INFO

Fund Manager Rahul Singh (Since 3 months) Meeta Shetty (Since 3 months)

ISIN INF277K019A3

Fund Family Tata

P/E Ratio 32.77

P/B Ratio 4.11

Launch Date December 28, 2015

Benchmark IISL Nifty Pharma TR INR

SECTOR WEIGHTINGS (%)

Financial 0.0%

Industrial 0.0%

Technology 0.0%

Basic Materials 0.0%

Consumer Cyclical 0.0%

Utilities Services 0.0%

Healthcare Services 100.00%

Energy Services 0.00%

Communication Services 0.00%

Consumer Defensive 0.00%

Real Estate 0.00%

INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

Top Rated
Top Performing

-

Best Sector Healthcare Funds

NAME	LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
Mirae Asset Healthcare Dir Gr	14.548	42.68%	581 cr	0.78%	-
Nippon India Pharma Fund - Direct Plan - Growth Plan	202.102	35.17%	2,992 cr	1.29%	-